Omeros Corp. (OMER)
19.29
+1.07
(+5.87%)
USD |
NASDAQ |
Aug 27, 15:58
Omeros Enterprise Value : 1.478B for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 1.478B |
| August 25, 2026 | 1.555B |
| August 24, 2026 | 1.558B |
| August 21, 2026 | 1.554B |
| August 20, 2026 | 1.508B |
| August 19, 2026 | 1.491B |
| August 18, 2026 | 1.404B |
| August 17, 2026 | 1.416B |
| August 14, 2026 | 1.404B |
| August 13, 2026 | 1.416B |
| August 12, 2026 | 1.153B |
| August 11, 2026 | 1.145B |
| August 10, 2026 | 1.147B |
| August 07, 2026 | 1.120B |
| August 06, 2026 | 1.113B |
| August 05, 2026 | 1.077B |
| August 04, 2026 | 1.098B |
| August 03, 2026 | 1.070B |
| July 31, 2026 | 1.018B |
| July 30, 2026 | 1.025B |
| July 29, 2026 | 1.006B |
| July 28, 2026 | 978.07M |
| July 27, 2026 | 982.39M |
| July 24, 2026 | 870.66M |
| July 23, 2026 | 905.98M |
| Date | Value |
|---|---|
| July 22, 2026 | 874.26M |
| July 21, 2026 | 851.92M |
| July 20, 2026 | 859.12M |
| July 17, 2026 | 863.45M |
| July 16, 2026 | 829.57M |
| July 15, 2026 | 912.47M |
| July 14, 2026 | 921.84M |
| July 13, 2026 | 886.52M |
| July 10, 2026 | 905.98M |
| July 09, 2026 | 905.26M |
| July 08, 2026 | 903.10M |
| July 07, 2026 | 909.59M |
| July 06, 2026 | 910.31M |
| July 02, 2026 | 833.89M |
| July 01, 2026 | 843.27M |
| June 30, 2026 | 850.47M |
| June 29, 2026 | 888.82M |
| June 26, 2026 | 799.54M |
| June 25, 2026 | 947.14M |
| June 24, 2026 | 937.06M |
| June 23, 2026 | 929.86M |
| June 22, 2026 | 919.06M |
| June 18, 2026 | 915.46M |
| June 17, 2026 | 869.38M |
| June 16, 2026 | 857.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.166T |
| Talphera, Inc. | 54.82M |
| Hyperion DeFi, Inc. | 51.14M |
| ANI Pharmaceuticals, Inc. | 1.947B |
| Corcept Therapeutics, Inc. | 12.63B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.637M |
| Revenue (Quarterly) | 28.53M |
| Total Expenses (Quarterly) | 21.89M |
| EPS Diluted (Quarterly) | 0.1476 |
| Gross Profit Margin (Quarterly) | 96.50% |
| Profit Margin (Quarterly) | 23.26% |
| Earnings Yield | 7.45% |
| Normalized Earnings Yield | 8.739 |